Market Outlook - Short Term - MoneyControl.com
Market conditions are slightly mix, so the propensity would be or the inclination would be to take profits where there are. I think there will be profits on Jubilant on listing. So, at least high net worth individuals (HNI) crowd will rush to protect

Coventry Health Care Reports Fourth Quarter Earnings of $0.74 per - Yahoo Finance
BETHESDA, Md.–(BUSINESS WIRE)–Coventry Health Care, Inc. (NYSE: CVH - News ) today reported consolidated operating results for the quarter ended December 31, 2009. Operating revenues totaled $3.4 billion for the quarter with net earnings of $109.1

XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in - Stockhouse
XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced that enrollment is underway in a 325-patient Phase 2b dose-ranging clinical trial of its antibody candidate, XOMA 052, in Type 2 diabetes patients

AXIS Posts Q4, Full Year Net Income Gains; Conference Call Details - Insurance Journal
Bermuda-based AXIS Capital Holdings Limited reported net income for the fourth quarter of 2009 of $282 million, or $1.87 per diluted common share, compared with net income of $131 million, or $0.88 per diluted common share in Q4 2008. Net income for

BUYINS.NET: ECA, RX, ALU, BEC, DPL, HE Expected To Be Lower After - TMCnet
Feb 09, 2010 (M2 PRESSWIRE via COMTEX) — BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 11th and determining how the stocks have performed after their last 12 quarterly

RTI Biologics Announces 2009 Year End, Fourth Quarter Results - MSN Money
Revenues were $42.0 million for the fourth quarter of 2009, representing a 12 percent increase compared to revenues of $37.4 million for the fourth quarter of 2008. Revenues for the full year 2009 were $164.5 million, representing a 12 percent

UMB Fund Services Welcomes W.P. Stewart & Co. Growth Fund into - Yahoo Finance
By allowing many independent funds to share certain fixed administrative costs and jointly fund industry, including administration and fund accounting, alternative investment services, investor services and transfer agency, marketing and

Nabors’ 4Q2009 Results Expected to Exceed Mean Estimates Excluding - Biloxi Sun Herald
HAMILTON, Bermuda, Feb. 9 — /PRNewswire-FirstCall/ — Nabors Industries Ltd. (NYSE: NBR) today announced that it expects its fourth quarter results to modestly exceed mean estimates of $0.16 per diluted share, excluding estimated non-cash, pre-tax

Market Outlook - Short Term - MoneyControl.com
Market conditions are slightly mix, so the propensity would be or the inclination would be to take profits where there are. I think there will be profits on Jubilant on listing. So, at least high net worth individuals (HNI) crowd will rush to protect

Coventry Health Care Reports Fourth Quarter Earnings of $0.74 per - Yahoo Finance
BETHESDA, Md.–(BUSINESS WIRE)–Coventry Health Care, Inc. (NYSE: CVH - News ) today reported consolidated operating results for the quarter ended December 31, 2009. Operating revenues totaled $3.4 billion for the quarter with net earnings of $109.1

XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in - Stockhouse
XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced that enrollment is underway in a 325-patient Phase 2b dose-ranging clinical trial of its antibody candidate, XOMA 052, in Type 2 diabetes patients

AXIS Posts Q4, Full Year Net Income Gains; Conference Call Details - Insurance Journal
Bermuda-based AXIS Capital Holdings Limited reported net income for the fourth quarter of 2009 of $282 million, or $1.87 per diluted common share, compared with net income of $131 million, or $0.88 per diluted common share in Q4 2008. Net income for

BUYINS.NET: ECA, RX, ALU, BEC, DPL, HE Expected To Be Lower After - TMCnet
Feb 09, 2010 (M2 PRESSWIRE via COMTEX) — BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, February 11th and determining how the stocks have performed after their last 12 quarterly

RTI Biologics Announces 2009 Year End, Fourth Quarter Results - MSN Money
Revenues were $42.0 million for the fourth quarter of 2009, representing a 12 percent increase compared to revenues of $37.4 million for the fourth quarter of 2008. Revenues for the full year 2009 were $164.5 million, representing a 12 percent

UMB Fund Services Welcomes W.P. Stewart & Co. Growth Fund into - Yahoo Finance
By allowing many independent funds to share certain fixed administrative costs and jointly fund industry, including administration and fund accounting, alternative investment services, investor services and transfer agency, marketing and

Nabors’ 4Q2009 Results Expected to Exceed Mean Estimates Excluding - Biloxi Sun Herald
HAMILTON, Bermuda, Feb. 9 — /PRNewswire-FirstCall/ — Nabors Industries Ltd. (NYSE: NBR) today announced that it expects its fourth quarter results to modestly exceed mean estimates of $0.16 per diluted share, excluding estimated non-cash, pre-tax